VR Logo

Claris Lifesciences Ltd. download report


Healthcare | Drugs & Pharma

Claris Lifesciences Ltd. Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2021 Claris Lifesciences Ltd. director's report Claris Lifesciences Ltd. auditor's report Claris Lifesciences Ltd. account notes
2020 Claris Lifesciences Ltd. Annual Report Claris Lifesciences Ltd. chairman speech Claris Lifesciences Ltd. director's report Claris Lifesciences Ltd. management discussion Claris Lifesciences Ltd. corporate governance Claris Lifesciences Ltd. auditor's report Claris Lifesciences Ltd. account notes
2019 Claris Lifesciences Ltd. Annual Report Claris Lifesciences Ltd. chairman speech Claris Lifesciences Ltd. director's report Claris Lifesciences Ltd. management discussion Claris Lifesciences Ltd. corporate governance Claris Lifesciences Ltd. auditor's report Claris Lifesciences Ltd. account notes
2018 Claris Lifesciences Ltd. Annual Report Claris Lifesciences Ltd. chairman speech Claris Lifesciences Ltd. director's report Claris Lifesciences Ltd. management discussion Claris Lifesciences Ltd. corporate governance Claris Lifesciences Ltd. auditor's report Claris Lifesciences Ltd. account notes
2017 Claris Lifesciences Ltd. Annual Report Claris Lifesciences Ltd. chairman speech Claris Lifesciences Ltd. director's report Claris Lifesciences Ltd. management discussion Claris Lifesciences Ltd. corporate governance Claris Lifesciences Ltd. auditor's report Claris Lifesciences Ltd. account notes
2016 Claris Lifesciences Ltd. Annual Report Claris Lifesciences Ltd. chairman speech Claris Lifesciences Ltd. director's report Claris Lifesciences Ltd. management discussion Claris Lifesciences Ltd. corporate governance Claris Lifesciences Ltd. auditor's report Claris Lifesciences Ltd. account notes
2015 Claris Lifesciences Ltd. Annual Report Claris Lifesciences Ltd. chairman speech Claris Lifesciences Ltd. director's report Claris Lifesciences Ltd. management discussion Claris Lifesciences Ltd. corporate governance Claris Lifesciences Ltd. auditor's report Claris Lifesciences Ltd. account notes
2013 Claris Lifesciences Ltd. Annual Report Claris Lifesciences Ltd. chairman speech Claris Lifesciences Ltd. director's report Claris Lifesciences Ltd. management discussion Claris Lifesciences Ltd. corporate governance Claris Lifesciences Ltd. auditor's report Claris Lifesciences Ltd. account notes
2012 Claris Lifesciences Ltd. Annual Report Claris Lifesciences Ltd. chairman speech Claris Lifesciences Ltd. director's report Claris Lifesciences Ltd. management discussion Claris Lifesciences Ltd. corporate governance Claris Lifesciences Ltd. auditor's report Claris Lifesciences Ltd. account notes
2011 Claris Lifesciences Ltd. Annual Report Claris Lifesciences Ltd. chairman speech Claris Lifesciences Ltd. director's report Claris Lifesciences Ltd. management discussion Claris Lifesciences Ltd. corporate governance Claris Lifesciences Ltd. auditor's report Claris Lifesciences Ltd. account notes
2010 Claris Lifesciences Ltd. Annual Report Claris Lifesciences Ltd. chairman speech Claris Lifesciences Ltd. director's report Claris Lifesciences Ltd. management discussion Claris Lifesciences Ltd. corporate governance Claris Lifesciences Ltd. auditor's report Claris Lifesciences Ltd. account notes

About The Company

Business: Wholesale of pharmaceutical and medical goods

Incorporated: 1994

Chairman: Surrinder Lal Kapur

Managing Director: Arjun Handa

Listing: BSE: 533288

Country: India

Headquarters: Ahmedabad, Gujarat

Website: www.clarislifesciences.com

Key Facts

Market cap: ₹2,163.88 Cr

Revenue (TTM): ₹--

Earnings (TTM): ₹-0.27 Cr

Cash: ₹0.48 Cr

Total Debt: ₹21.01 Cr

Promoters' ownership: 50.13%

Liquidity:

52 Week range: ₹-- - --

Face value: ₹10.00

Shares outstanding: 5,45,67,765

10 Years Aggregate:

  • CFO: ₹609.41 Cr
  • EBITDA: ₹973.84 Cr
  • Net Profit: ₹663.74 Cr

Stock Performance

Time Period Claris Lifesciences S&P BSE Sensex* S&P BSE Healthcare*
YTD11.301.05-11.29
1 month1.678.655.31
3 months12.997.341.44
1 Year24.418.45-11.84
3 Years13.7017.0722.75
5 Years16.1012.7710.85
10 Years--12.8312.27
As on 14-Mar-2018 *As on 08-Aug-2022
Year Claris Lifesciences S&P BSE Sensex S&P BSE Healthcare
201711.3327.910.49
201648.381.95-12.88
201519.05-5.0315.06
2014-9.1229.8947.43

Review & Analysis